Penta-peptide ATN-161 based neutralization mechanism of SARS-CoV-2 spike protein.
Biochem Biophys Rep
; 28: 101170, 2021 Dec.
Article
in English
| MEDLINE | ID: covidwho-1509587
ABSTRACT
SARS-CoV-2 has become a big challenge for the scientific community worldwide. SARS-CoV-2 enters into the host cell by the spike protein binding with an ACE2 receptor present on the host cell. Developing safe and effective inhibitor appears an urgent need to interrupt the binding of SARS-CoV-2 spike protein with ACE2 receptor in order to reduce the SARS-CoV-2 infection. We have examined the penta-peptide ATN-161 as potential inhibitor of ACE2 and SARS-CoV-2 spike protein binding, where ATN-161 has been commercially approved for the safety and possess high affinity and specificity towards the receptor binding domain (RBD) of S1 subunit in SARS-CoV-2 spike protein. We carried out experiments and confirmed these phenomena that the virus bindings were indeed minimized. ATN-161 peptide can be used as an inhibitor of protein-protein interaction (PPI) stands as a crucial interaction in biological systems. The molecular docking finding suggests that the binding energy of the ACE2-spike protein complex is reduced in the presence of ATN-161. Protein-protein docking binding energy (-40.50 kcal/mol) of the spike glycoprotein toward the human ACE2 and binding of ATN-161 at their binding interface reduced the biding energy (-26.25 kcal/mol). The finding of this study suggests that ATN-161 peptide can mask the RBD of the spike protein and be considered as a neutralizing candidate by binding with the ACE2 receptor. Peptide-based masking of spike S1 protein (RBD) and its neutralization is a highly promising strategy to prevent virus penetration into the host cell. Thus masking of the RBD leads to the loss of receptor recognition property which can reduce the chance of infection host cells.
ACE2; ACE2, Angiotensin-converting-enzyme 2; ATN-161; MERS-CoV, Middle East respiratory syndrome coronavirus; PBS, Phosphate buffer saline; PPI, Protein-protein interaction; PVDF, Polyvinylidene difluoride; Protein-protein interactions; RBD, receptor binding domain; RBM, receptor binding motif; SARS-CoV-1, severe acute respiratory syndrome coronavirus 1; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; Severe acute respiratory syndrome coronavirus-2; Western blot
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Journal:
Biochem Biophys Rep
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS